U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H23NO3
Molecular Weight 313.3908
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BIPHENAMINE

SMILES

CCN(CC)CCOC(=O)C1=C(O)C(=CC=C1)C2=CC=CC=C2

InChI

InChIKey=HLDCSYXMVXILQC-UHFFFAOYSA-N
InChI=1S/C19H23NO3/c1-3-20(4-2)13-14-23-19(22)17-12-8-11-16(18(17)21)15-9-6-5-7-10-15/h5-12,21H,3-4,13-14H2,1-2H3

HIDE SMILES / InChI

Description

Biphenamine is a local anesthetic with antibacterial and antifungal properties. It has been used in the treatment of seborrheic scalp disorders.

Approval Year

Unknown
149124
Patents

Patents

20030212026
2
Name Type Language
XENYSALATE
INN   WHO-DD  
INN  
Preferred Name English
BIPHENAMINE
MI  
Common Name English
Xenysalate [WHO-DD]
Common Name English
(1,1'-BIPHENYL)-3-CARBOXYLIC ACID, 2-HYDROXY-2-(DIETHYLAMINO)ETHYL ESTER
Common Name English
xenysalate [INN]
Common Name English
BIPHENAMINE [MI]
Common Name English
2-(DIETHYLAMINO)ETHYL 2-HYDROXY-3-BIPHENYLCARBOXYLATE
Systematic Name English
Classification Tree Code System Code
WHO-VATC QD11AC09
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
WHO-ATC D11AC09
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
NCI_THESAURUS C29700
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
Code System Code Type Description
EVMPD
SUB00108MIG
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY
FDA UNII
65X88IL51X
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY
NCI_THESAURUS
C79881
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY
INN
1254
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY
ChEMBL
CHEMBL2110895
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY
DRUG BANK
DB13815
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY
EPA CompTox
DTXSID4063086
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY
DRUG CENTRAL
3027
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY
MERCK INDEX
m1026
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY Merck Index
SMS_ID
100000079356
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY
ECHA (EC/EINECS)
222-686-2
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY
CAS
3572-52-9
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY
PUBCHEM
21720
Created by admin on Mon Mar 31 18:50:39 GMT 2025 , Edited by admin on Mon Mar 31 18:50:39 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of BIPHENAMINE
SALT/SOLVATE (PARENT)
Structure of BIPHENAMINE HYDROCHLORIDE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966